Literature DB >> 1674126

Serotonin, but neither noradrenaline nor GABA, inhibits capsaicin-evoked release of immunoreactive somatostatin from slices of rat spinal cord.

Y Kuraishi1, M Minami, M Satoh.   

Abstract

It has been suggested that somatostatin is involved in nociceptive transmission in the dorsal horn and that it is contained in small primary afferent neurons. In the present experiments, to elucidate neural systems inhibiting the release of somatostatin from the primary afferent terminals, we examined the effects of serotonin, noradrenaline and gamma-aminobutyric acid on the capsaicin-evoked, dorsal-rhizotomy-sensitive and tetrodotoxin-insensitive release of immunoreactive somatostatin, 98.7% of which was somatostatin itself, from the dorsal-half slices of lumbar and cervical enlargements of rat spinal cord. Serotonin (30-100 microM) suppressed the evoked release in a concentration-dependent manner, and the suppression was antagonized by methysergide (100 microM). The evoked release of immunoreactive somatostatin was not inhibited by noradrenaline (100 microM) or gamma-aminobutyric acid (100 microM). The present results suggest that the serotonergic systems exert an inhibitory effect on the release of somatostatin from the central terminals of primary sensory neurons.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1674126     DOI: 10.1016/0168-0102(91)90025-t

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  2 in total

1.  Neonatal damage to the rat's infraorbital nerve upregulates both galanin and neuropeptide Y in individual vibrissae-related primary afferent axons.

Authors:  C B Boylan; K Davis; C A Bennett-Clarke; R W Rhoades
Journal:  Exp Brain Res       Date:  1996-12       Impact factor: 1.972

2.  An immunohistochemical study of the antinociceptive effect of calcitonin in ovariectomized rats.

Authors:  Bunji Takayama; Shin-ichi Kikuchi; Shin-ichi Konno; Miho Sekiguchi
Journal:  BMC Musculoskelet Disord       Date:  2008-12-15       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.